CVI Holdings’s Apexigen, Inc. Common Stock APGN Stock Holding History

CVI Holdings’s Portfolio APGN Stock Details APGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-150,000	Closed	-$75K	–	370
2023 Q1	$75K	Buy	+150,000	New	+$180K	0.03%	156
2022 Q2	–	Sell	-102,405	Closed	-$1.03M	–	979
2022 Q1	$1.03M	Buy	102,405 +2,405	+2%	+$24.1K	0.07%	382
2021 Q4	$1M	Hold	100,000	–	–	0.07%	352
2021 Q3	$995K	Hold	100,000	–	–	0.06%	349
2021 Q2	$990K	Buy	+100,000	New	+$991K	0.07%	325

Other funds holding APGN

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

CVI Holdings's APGN Position: Q2 2023 in Review

CVI Holdings sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2023, closing a stake of 150,000 shares — an estimated $75K sold.

CVI Holdings first reported a position in APGN in Q2 2021 and held it in 5 quarters. The position peaked at $1.03M in Q1 2022. 17 funds tracked by Wall St. Rank hold APGN as of Q2 2023.

CVI Holdings reported no remaining Apexigen, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 150,000 Apexigen, Inc. Common Stock shares in Q2 2023, an estimated $75K.
CVI Holdings first reported a position in Apexigen, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
CVI Holdings's Apexigen, Inc. Common Stock position peaked at $1.03M in Q1 2022.
17 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.